Cognition Therapeutics (CGTX) Current Leases (2022 - 2026)
Cognition Therapeutics (CGTX) reported Current Leases of $95000.0 for Q1 2026, down 51.03% year-over-year from $194000.0 in Q1 2025, and down 30.15% on a QoQ basis from $136000.0 in Q4 2025.
Cognition Therapeutics (CGTX) has 5 years of Current Leases data on file, last reported at $95000.0 in Q1 2026.
- Quarterly Current Leases fell 51.03% year-over-year to $95000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $95000.0 (down 51.03% YoY) and the FY2025 annual result came in at $136000.0, down 29.53% from the prior year.
- Current Leases eased to $95000.0 in Q1 2026 per CGTX's latest filing, from $136000.0 in the prior quarter.
- Across five years, Current Leases topped out at $198000.0 in Q2 2025 and bottomed at $95000.0 in Q1 2026.
- The 5-year median for Current Leases is $168000.0 (2025), against an average of $163352.9.
- The widest annual swing landed in 2023, when Current Leases jumped 49.12%; it then plunged 51.03% in 2026.
- Tracing CGTX's Current Leases over 5 years: stood at $149000.0 in 2022, then climbed by 16.78% to $174000.0 in 2023, then climbed by 10.92% to $193000.0 in 2024, then dropped by 29.53% to $136000.0 in 2025, then sank by 30.15% to $95000.0 in 2026.
- Per Business Quant, the three latest CGTX Current Leases figures stand at $95000.0 (Q1 2026), $136000.0 (Q4 2025), and $168000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 720.00 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - | 95,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95,000.00 |
| Dec 31, 2025 | 136,000.00 |
| Sep 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 198,000.00 |
| Mar 31, 2025 | 194,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 184,000.00 |
| Mar 31, 2024 | 180,000.00 |
| Dec 31, 2023 | 174,000.00 |
| Sep 30, 2023 | 170,000.00 |
| Jun 30, 2023 | 166,000.00 |
| Mar 31, 2023 | 157,000.00 |
| Dec 31, 2022 | 149,000.00 |
| Sep 30, 2022 | 114,000.00 |
| Jun 30, 2022 | 161,000.00 |
| Mar 31, 2022 | 150,000.00 |